ROS1 rearrangements in lung adenocarcinomas are defined by diffuse strong immunohistochemical expression of ROS1
| Autor: | Sandra A O'Toole, Laveniya Satgunaseelan, Ki Yuk Lam, Mikaela Holmes, Wendy A Cooper, Andrew J. Colebatch, Jordan Butler, Geraldine Tierney, Ruta Gupta, Annabelle Mahar, Timothy Fielder |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Gene Rearrangement
Pathology medicine.medical_specialty Lung Neoplasms Lung Molecular pathology Adenocarcinoma of Lung Adenocarcinoma Protein-Tyrosine Kinases Biology Pathology and Forensic Medicine Staining medicine.anatomical_structure Proto-Oncogene Proteins In situ hybridisation ROS1 medicine Humans Gene Arrangements Fish Immunohistochemistry |
| Zdroj: | Pathology. 54:399-403 |
| ISSN: | 0031-3025 |
| Popis: | A small subset of lung adenocarcinomas harbour ROS1 gene arrangements and are amenable to tyrosine kinase inhibitor therapy. Current practice in Australia involves screening for ROS1 rearrangements in adenocarcinomas using ROS1 immunohistochemistry (IHC) followed by confirmatory molecular testing such as fluorescence in situ hybridisation (FISH), if other known genetic driver alterations are absent. The best threshold to determine ROS1 IHC positivity is not well defined, however, and this study aims to determine the optimal threshold for ROS1 IHC screening to identify ROS1-rearranged lung adenocarcinomas. A total of 177 lung adenocarcinomas tested for a ROS1 rearrangement by FISH at our institution between 2017 and 2020 due to presence of ROS1 IHC staining were included in the study. ROS1 IHC staining was assessed by scoring the staining intensity (0, 1, 2, or 3+) and multiplying by the percentage of positive cells to generate an H-score. IHC H-scores were compared with FISH. Of 177 cases, 32 (18%) were ROS1 FISH-positive and 145 (82%) were negative. FISH-positive cases had a median H-score of 300 (range 200-300; mean 290.3) and negative cases had a median H-score of 40 (range 0-300; mean 63). All FISH-positive cases showed strong and diffuse IHC positivity. Using a threshold H-score of 200, the sensitivity of identifying ROS1 rearrangements was 100% and the specificity was 95% amongst cases referred with ROS1 IHC positivity. Adenocarcinomas with a FISH-confirmed ROS1 rearrangement demonstrate diffuse, strong (2-3+) IHC staining. Cases with weak, patchy ROS1 IHC staining are not associated with ROS1 rearrangements and in these cases FISH testing is of little to no utility. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect